01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $22.13B
1 older move runs past ±150% (largest +202.6%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $22.13B | −11.1% | 10-K | |
| FY2024 | $24.90B | +7.4% | 10-K | |
| FY2023 | $23.19B | +1.0% | 10-K | |
| FY2022 | $22.96B | −8.8% | 10-K | |
| FY2021 | $25.18B | −12.1% | 10-K | |
| FY2020 | $28.64B | +29.7% | 10-K | |
| FY2019 | $22.09B | −10.1% | 10-K | |
| FY2018 | $24.57B | −20.2% | 10-K | |
| FY2017 | $30.80B | +16.9% | 10-K | |
| FY2016 | $26.35B | +25.0% | 10-K | |
| FY2015 | $21.07B | +76.8% | 10-K | |
| FY2014 | $11.92B | +202.6% | 10-K | |
| FY2013 | $3.94B | −44.2% | 10-K | |
| FY2012 | $7.05B | −7.2% | 10-K | |
| FY2011 | $7.61B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is GILEAD SCIENCES, INC.'s current long-term debt?
GILEAD SCIENCES, INC. (GILD) annual long-term debt for 2025 was $22.13B, a 11.11% decline from 2024. GILEAD SCIENCES, INC. long-term debt for the quarter ending March 31, 2026 was $20.86B.
What was GILEAD SCIENCES, INC.'s long-term debt in 2024?
GILEAD SCIENCES, INC. annual long-term debt for 2024 was $24.90B, a 7.36% increase from 2023.
What was GILEAD SCIENCES, INC.'s long-term debt in 2023?
GILEAD SCIENCES, INC. annual long-term debt for 2023 was $23.19B, a 1.01% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year long-term debt CAGR?
GILEAD SCIENCES, INC. long-term debt grew at a compound annual growth rate (CAGR) of 5.03% from FY2020 to FY2025, going from $28.64B to $22.13B over 5 years.
- Company
- GILEAD SCIENCES, INC.
- Ticker
- GILD
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)